Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

about

Opinions of nephrologists on the efficacy and tolerance of statins in hemodialysis patients.

P2860

Q53549230-3DDE94BC-4806-4D58-82CF-F0C11EEF12DE

P2860

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

Item

http://www.wikidata.org/entity/Q35675305

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@ast

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@en

type

Item

label

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@ast

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@en

prefLabel

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@ast

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@en

P1476

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

@en

P2093

Ali Motabar

http://www.w3.org/2001/XMLSchema#string

Juliana Gazallo

http://www.w3.org/2001/XMLSchema#string

Padmini Varadrajan

http://www.w3.org/2001/XMLSchema#string

Prakash C Deedwania

http://www.w3.org/2001/XMLSchema#string

Ramdas G Pai

http://www.w3.org/2001/XMLSchema#string

Waqas Aftab

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Left ventricular hypertrophy in the renal patient.

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients

P304

105-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0035-1547373

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26060381

http://www.w3.org/2001/XMLSchema#string

P932

4452604

http://www.w3.org/2001/XMLSchema#string

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

about

P2860

P2860

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932